Skip to main content
  • Saved

made a Post

Pharmacists' Perspectives of Biosimilars: A Systematic Review - BioDrugs

Pharmacists' Perspectives of Biosimilars: A Systematic Review - BioDrugs

Source :

https://link.springer.com/article/10.1007/s40259-022-00541-x

Background and Objective While biosimilars are less expensive than their originator biologics, various factors are known to impede their uptake in clinical practice including concerns regarding their interchangeability, efficacy, and safety. Pharmacists are well positioned to promote the adoption of biosimilars, thus, the aim of the review was to assess pharmacists' knowledge and perceptions of biosimilars to identify the need for pharmacist-directed biosimilar education.


Conclusions: Pharmacists’ knowledge and perception about biosimilars varied and were limited, especially about interchangeability and substitution, efficacy, safety, and indication extrapolation. A better understanding of biosimilars amongst pharmacists could help them to encourage prescribers’ acceptance of biosimilars.